Burrill Life Sciences Capital Fund, Burrill Indiana Life Sciences Capital Fund, and G. Steven Burrill complete sale of $46.3 million of Common Stock in public offering by Pharmasset
Client(s) Burrill & Company LLC
Jones Day represented Burrill Life Sciences Capital Fund, L.P., Burrill Indiana Life Sciences Capital Fund, L.P., Delaware limited partnerships, and G. Steven Burrill, as selling stockholders, in connection with the sale of $46.3 million of Common Stock in a public offering by Pharmasset, Inc., a pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections.